{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:27:26Z","timestamp":1787729246505,"version":"build-2784847793"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS052563"],"award-info":[{"award-number":["NS052563"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","award":["TG2-01169"],"award-info":[{"award-number":["TG2-01169"]}],"id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["8P41GM103481"],"award-info":[{"award-number":["8P41GM103481"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,18]]},"DOI":"10.1093\/neuonc\/nox215","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T20:22:15Z","timestamp":1510086135000},"page":"764-775","source":"Crossref","is-referenced-by-count":33,"title":["A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma"],"prefix":"10.1093","volume":"20","author":[{"given":"Dan R","family":"Laks","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A","family":"Oses-Prieto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, UCSF, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro G","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Chand","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, UCSF, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B","family":"Azzam","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur A","family":"Gholkar","sequence":"additional","affiliation":[{"name":"Chemistry, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantzen","family":"Sperry","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Condro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serli","family":"Nazarian","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjelica","family":"Cardenas","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y S","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"France","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Orozco","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koppany","family":"Visnyei","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Crisman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Z","family":"Torres","sequence":"additional","affiliation":[{"name":"Chemistry, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Coppola","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"},{"name":"Department of Neurology, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma L","family":"Burlingame","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, UCSF, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harley I","family":"Kornblum","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience & Human Behavior, UCLA, Los Angeles, California"},{"name":"Department of Molecular and Medical Pharmacology, UCLA"},{"name":"Chemistry, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20180518103623_CIT0001","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"6483","key":"key\n\t\t\t\t20180518103623_CIT0002","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","article-title":"The TOR pathway: a target for cancer therapy","volume":"4","author":"Bjornsti","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"key\n\t\t\t\t20180518103623_CIT0004","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"issue":"2","key":"key\n\t\t\t\t20180518103623_CIT0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"2","key":"key\n\t\t\t\t20180518103623_CIT0008","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/1535-7163.MCT-08-0680","article-title":"Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells","volume":"8","author":"Gallia","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0009","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma","volume":"5","author":"Cloughesy","year":"2008","journal-title":"PLoS Med"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/mol.54.5.815","article-title":"Studies on the mechanism of resistance to rapamycin in human cancer cells","volume":"54","author":"Hosoi","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0011","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","author":"Thoreen","year":"2009","journal-title":"Autophagy"},{"issue":"37","key":"key\n\t\t\t\t20180518103623_CIT0012","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1073\/pnas.1103746108","article-title":"The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1535-7163.MCT-11-0578","article-title":"Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells","volume":"11","author":"Liu","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"26","key":"key\n\t\t\t\t20180518103623_CIT0014","doi-asserted-by":"crossref","first-page":"21796","DOI":"10.1074\/jbc.M111.304626","article-title":"The PP242 mammalian target of rapamycin (mTOR) inhibitor activates extracellular signal-regulated kinase (ERK) in multiple myeloma cells via a target of rapamycin complex 1 (TORC1)\/eukaryotic translation initiation factor 4E (eIF-4E)\/RAF pathway and activation is a mechanism of resistance","volume":"287","author":"Hoang","year":"2012","journal-title":"J Biol Chem"},{"issue":"7","key":"key\n\t\t\t\t20180518103623_CIT0015","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1158\/0008-5472.CAN-11-2195","article-title":"Rapamycin resistance is linked to defective regulation of Skp2","volume":"72","author":"Totary-Jain","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.05.003","article-title":"Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells","volume":"324","author":"Juengel","year":"2012","journal-title":"Cancer Lett"},{"issue":"8","key":"key\n\t\t\t\t20180518103623_CIT0017","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/neuonc\/noq052","article-title":"mTOR signaling in glioblastoma: lessons learned from bench to bedside","volume":"12","author":"Akhavan","year":"2010","journal-title":"Neuro Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0018","first-page":"255","article-title":"Inhibition of mTOR activates the MAPK pathway in glioblastoma multiforme","volume":"6","author":"Albert","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"key\n\t\t\t\t20180518103623_CIT0019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.03.012","article-title":"Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma","volume":"29","author":"Wei","year":"2016","journal-title":"Cancer Cell"},{"issue":"3","key":"key\n\t\t\t\t20180518103623_CIT0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"key\n\t\t\t\t20180518103623_CIT0021","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/neuonc\/now045","article-title":"Large-scale assessment of the gliomasphere model system","volume":"18","author":"Laks","year":"2016","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20180518103623_CIT0022","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-61779-264-9_17","article-title":"Phosphoproteomics using iTRAQ","volume":"779","author":"Jones","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0023","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/bioinformatics\/btp026","article-title":"KEA: kinase enrichment analysis","volume":"25","author":"Lachmann","year":"2009","journal-title":"Bioinformatics"},{"issue":"6","key":"key\n\t\t\t\t20180518103623_CIT0024","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1091\/mbc.e09-07-0598","article-title":"A specific form of phospho protein phosphatase 2 regulates anaphase-promoting complex\/cyclosome association with spindle poles","volume":"21","author":"Torres","year":"2010","journal-title":"Mol Biol Cell"},{"issue":"6559","key":"key\n\t\t\t\t20180518103623_CIT0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key\n\t\t\t\t20180518103623_CIT0027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj3030027","article-title":"The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells","volume":"303","author":"Saito","year":"1994","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20180518103623_CIT0028","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem J"},{"issue":"5264","key":"key\n\t\t\t\t20180518103623_CIT0029","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.272.5264.1023","article-title":"Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly","volume":"272","author":"Rubinfeld","year":"1996","journal-title":"Science"},{"issue":"6","key":"key\n\t\t\t\t20180518103623_CIT0030","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1073\/pnas.95.6.3020","article-title":"Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"key\n\t\t\t\t20180518103623_CIT0031","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","article-title":"Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"issue":"Pt 5","key":"key\n\t\t\t\t20180518103623_CIT0032","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1242\/jcs.01697","article-title":"Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons","volume":"118","author":"Trivedi","year":"2005","journal-title":"J Cell Sci"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0033","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/cc.27728","article-title":"Inhibition of GSK-3\u03b2 activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells","volume":"13","author":"Sokolosky","year":"2014","journal-title":"Cell Cycle"},{"issue":"11","key":"key\n\t\t\t\t20180518103623_CIT0034","doi-asserted-by":"crossref","first-page":"8974","DOI":"10.18632\/oncotarget.3291","article-title":"GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth","volume":"6","author":"Koo","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"key\n\t\t\t\t20180518103623_CIT0035","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1158\/0008-5472.CAN-13-2946","article-title":"Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth","volume":"74","author":"Koo","year":"2014","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180518103623_CIT0036","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1242\/jcs.111.10.1351","article-title":"Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium","volume":"111","author":"Lucas","year":"1998","journal-title":"J Cell Sci"},{"issue":"4","key":"key\n\t\t\t\t20180518103623_CIT0037","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1097-4547(19980515)52:4<445::AID-JNR8>3.0.CO;2-9","article-title":"Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phosphorylation of microtubule-associated protein 1B in developing neuronal cells","volume":"52","author":"Garc\u00eda-P\u00e9rez","year":"1998","journal-title":"J Neurosci Res"},{"issue":"4","key":"key\n\t\t\t\t20180518103623_CIT0038","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"key\n\t\t\t\t20180518103623_CIT0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2014.00153","article-title":"Microtubules and their role in cellular stress in cancer","volume":"4","author":"Parker","year":"2014","journal-title":"Front Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0040","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1158\/0008-5472.CAN-04-2501","article-title":"Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity","volume":"65","author":"Dong","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0041","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ccell.2015.05.009","article-title":"Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules","volume":"28","author":"Yu","year":"2015","journal-title":"Cancer Cell"},{"issue":"20","key":"key\n\t\t\t\t20180518103623_CIT0042","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/annonc\/mdu482","article-title":"A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors","volume":"26","author":"Tolcher","year":"2015","journal-title":"Ann Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180518103623_CIT0044","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1158\/1535-7163.MCT-11-1010","article-title":"ERK inhibition overcomes acquired resistance to MEK inhibitors","volume":"11","author":"Hatzivassiliou","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"key\n\t\t\t\t20180518103623_CIT0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2015.11.011","article-title":"Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression","volume":"29","author":"Hayes","year":"2016","journal-title":"Cancer Cell"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/20\/6\/764\/24832694\/nox215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T17:56:24Z","timestamp":1659808584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/20\/6\/764\/4608067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,11,9]]},"published-print":{"date-parts":[[2018,5,18]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nox215","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2017,11,9]]}}}